Medtronic and Medtronic Foundation Partner to Address COVID-19 Surges with Focus on Equity

- Medtronic plc (NYSE:MDT) and the Medtronic Foundation announced an additional $3M USD for COVID-19 relief efforts a combination of financial resources, personal protective equipment (PPE) donations, and Medtronic employee engagement focused on underserved areas of India Brazil the United States and other global regions. This latest COVID-19 response expands Medtronic and Medtronic Foundation's COVID-19 support to $56M USD .

The Medtronic Foundation is partnering with established nonprofit organizations already on the ground and actively working with communities to combat the COVID-19 surges. These new resources aim to:

  • Provide medical supplies and equipment such as personal protective equipment (PPE) and oxygen concentrators.
  • Supply temporary COVID-19 treatment sites and quarantine facilities.
  • Train frontline health workers, providing coronavirus health education.
  • Address vaccine hesitancy to prevent a third surge.

"The overwhelming surge of record-breaking COVID-19 cases and deaths in communities around the world show us how the pandemic exacerbates the social, economic, and health inequities for underserved communities," said Paurvi Bhatt , Medtronic Foundation president. "Together with our nonprofit partners and Medtronic employees, we are focusing this phase of our COVID-19 response on communities in immediate need of care and vaccines in India , Brazil , and the United States to enable more equitable access so people have an opportunity to survive this devastating pandemic."

Engaging Together
In addition to financial support to nonprofit partners and facilitating product donations, the Medtronic Foundation is matching 2:1 Medtronic employee and retiree donations to eligible nonprofit organizations worldwide and to the Medtronic Employee Emergency Assistance Fund (MEEAF) to support Medtronic employees and their families impacted by COVID-19.

For the 90,000+ global Medtronic employees, the Medtronic Foundation also is organizing virtual volunteer opportunities to support non-profit organizations responding to the COVID-19 surges include serving as vaccine ambassadors and training healthcare workers in underserved areas.

About Medtronic Foundation
Medtronic plc is the sole funder of Medtronic Foundation, whose focus is on improving lives for underserved populations worldwide, as well as supporting communities in which Medtronic employees live and give. For more information, please visit medtronicfoundation.org .

About Medtronic
Medtronic plc ( www.medtronic.com ), headquartered in Dublin, Ireland , is among the world's largest medical technology, services and solutions companies – alleviating pain, restoring health and extending life for millions of people around the world. Medtronic employs more than 90,000 people worldwide, serving physicians, hospitals and patients in more than 150 countries. The company is focused on collaborating with stakeholders around the world to take healthcare Further, Together.

Any forward-looking statements are subject to risks and uncertainties such as those described in Medtronic's periodic reports on file with the Securities and Exchange Commission. Actual results may differ materially from anticipated results.

Contacts:




Elizabeth Costello

John Jordan

Medtronic Foundation

Medtronic

Public Relations

Public Relations

+1-612-940-7693

+1-508-452-4891



Ryan Weispfenning


Medtronic


Investor Relations


+1-763-505-4626


(PRNewsfoto/Medtronic plc)

Cision View original content to download multimedia: https://www.prnewswire.com/news-releases/medtronic-and-medtronic-foundation-partner-to-address-covid-19-surges-with-focus-on-equity-301290496.html

SOURCE Medtronic plc

News Provided by PR Newswire via QuoteMedia

The Conversation (0)

Acne Vulgaris Treatment PrARAZLO Now Available to Patients Through British Columbia PharmaCare Public Drug Plan

Bausch Health, Canada Inc., part of Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), today announced that its topical prescription treatment for acne vulgaris, PrARAZLOTM (tazarotene lotion, 0.045% ww), is now available to patients through BC PharmaCare, the public drug program of British Columbia

ARAZLO is the only tazarotene lotion treatment approved by Health Canada for the topical treatment of acne vulgaris in patients 10 years of age and older.1 The listing by BC PharmaCare means ARAZLO is now available to patients on all public drug plans across Canada.

News Provided by ACCESSWIRE via QuoteMedia

Keep reading...Show less
Cleo Diagnostics

CLEO Appoints CRO to Manage U.S. Ovarian Cancer Clinical Trials

Ovarian cancer diagnostics company, Cleo Diagnostics Limited (ASX:COV) (CLEO, or the Company) is pleased to announce the appointment of international Contract Research Organization (CRO), Lindus Health, as a key partner for its U.S. clinical trials program.

Keep reading...Show less

Medtronic unveils the future of AI in GI: Genius Summit 2024 reveals innovations and collaborations that advance endoscopic care

AI-driven solutions and strategic alliances showcase Medtronic's promise to enhance the efficiency and effectiveness of endoscopy

Medtronic plc (NYSE: MDT), a global leader in healthcare technology, announced the latest advancements in artificial intelligence (AI) for endoscopic care by unveiling ColonPRO™, the latest generation software for the GI Genius™ intelligent endoscopy system, along with a strategic collaboration designed to enhance patient care.

News Provided by Canada Newswire via QuoteMedia

Keep reading...Show less

Knight to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference

Knight Therapeutics Inc. (TSX: GUD) ("Knight"), a leading pan-American (ex-US) specialty pharmaceutical company, announced today that Samira Sakhia, President and Chief Executive Officer, is scheduled to present a corporate update at the Bloom Burton & Co. Healthcare Investor Conference on Tuesday, April 16, 2024, at 10:30 a.m. ET at the Metro Toronto Convention Centre in Toronto. A copy of the presentation will be available at www.knighttx.com .

About Knight Therapeutics Inc.

News Provided by GlobeNewswire via QuoteMedia

Keep reading...Show less

New Documentary Released by Medtronic: "A Voice for Health"

Join us on a journey to Kenya and discover how Medtronic LABS is expanding access to essential healthcare.

Yesterday was World Health Day, and the theme this year is ‘My health, my right'. Over half the world's population can't access essential health services. The mission of Medtronic LABS is to change that. Watch as the team travels to Kenya to capture the everyday stories from people who utilize LABS' technology to better track their health

News Provided by ACCESSWIRE via QuoteMedia

Keep reading...Show less

The Medtronic Sphere-360 Pulse Field Ablation catheter, a new paradigm in single-shot ablation, demonstrates impressive results in treating paroxysmal atrial fibrillation

EHRA late-breaking data: Results highlight efficacy, safety, and durability of the novel PFA catheter that is fully integrated with Affera™ Mapping and Ablation System

Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced positive clinical trial safety and efficacy results for Sphere-360™, an investigational single-shot mapping and ablation catheter using pulsed field (PF) energy, for treatment of patients with paroxysmal atrial fibrillation (AFib). Interim findings from the first-in-human Sphere-360 study were presented as a late-breaking clinical trial at the European Heart Rhythm Association (EHRA) 2024 Annual Meeting .

News Provided by Canada Newswire via QuoteMedia

Keep reading...Show less

Latest Press Releases

Related News

×